AAN

Latest

AAN

·February 24, 2021·3 min read

People With Depression and Anxiety May Develop Alzheimer’s at Younger Age

People with depression and anxiety may be at greater risk of developing Alzheimer's disease earlier than those without the conditions. On average, people with depression developed Alzheimer's symptoms two years earlier, and those with anxiety three years earlier, than those who did not suffer from the mental health disorders. Read More

Featured Neurology Neuroscience

·February 23, 2021·3 min read

Exercise May Reduce Migraine Triggers

Migraine sufferers who embarked on two-and-a-half hours of moderate to vigorous exercise per week reported a significant decline in their migraine triggers, including stress, depression, and sleep problems. Read More

Featured Neurology Neuroscience

·February 23, 2021·2 min read

Loss of Sense of Smell and Taste May Last up to 5 Months After COVID-19

51% of COVID-19 patients report they experienced the loss of smell and taste up to five months after infection. On average, once their senses were restored, people reported a loss in sensitivity to smell and taste. Read More

Featured Neurology Neuroscience

·February 17, 2021·3 min read

White Matter Changes in Brain Found in Frontotemporal Dementia

Study reveals those with frontotemporal dementia have greater white matter hyperintensity than those with other forms of dementia. The amount of white matter hyperintensity was associated with the severity of FTD symptoms. Read More

This shows a pregnant woman rubbing her belly

Featured Neurology

·February 3, 2021·3 min read

Moms With MS at No More Risk of Pregnancy Complications Than Moms Without MS

Contrary to popular belief, women with multiple sclerosis may not be at higher risk for complications during pregnancy, such as gestational diabetes or still-birth. However, babies of mothers with MS are more likely to be induced or believed by elective C-sections. Read More

Featured Neurology Neuroscience

·January 27, 2021·3 min read

Can Large Fluid-Filled Spaces in the Brain Help Identify Those at Risk of Dementia?

Enlarged perivascular spaces around small blood vessels in the brain may be a biomarker for cognitive decline, and ultimately dementia, a new study reports. Read More

This shows a man, question marks and a skeleton with its brain showing

Featured Neurology Neuroscience

·January 14, 2021·4 min read

Memory May Be Preserved in Condition With Brain Changes Similar to Alzheimer’s Disease

While 40% of people with primary progressive aphasia have underlying Alzheimer's disease, a new study suggests they may not develop the memory problems associated with Alzheimer's. Read More

Featured Genetics Neurology Open Neuroscience Articles

·October 1, 2020·4 min read

Even in People With Parkinson’s Gene, Coffee May Be Protective

For carriers of the Parkinson's related LRRK2 gene, coffee consumption can help lower the risk of developing symptoms of the disease. Read More

Featured Neurology Neuroscience

·September 27, 2020·5 min read

Multiple Unapproved Drugs Found in “Brain Boosting” Supplements

Researchers identified five unapproved drugs in dangerous combinations and doses in over-the-counter cognitive enhancement drugs. Side effects of the unapproved drugs include increases and decreases in blood pressure, agitation, and sedation. Read More

Featured Genetics Neurology Neuroscience

·September 16, 2020·3 min read

Beyond Plaques and Tangles: Genetic Variation May Increase Risk of Cognitive Decline

A genetic variation that alters the metabolism of glutathione may be responsible for cognitive decline in people who do not have other associated biomarkers, a new study reports. Read More

Featured Neurology

·September 2, 2020·6 min read

Common Drugs Tied to Increased Risk of Cognitive Decline

Anticholinergic medications, commonly used for conditions including allergies, high blood pressure, Parkinson's disease, and motion sickness, have been linked to an increased risk of cognitive decline and memory problems, especially in those with genetic risk factors for Alzheimer's disease. Read More